InsiderFlow

Heartflow, Inc. Common Stock

$20.47-0.32 (-1.54%)

Prev Close

$20.79

Open

$20.79

High

$21.76

Low

$20.41

Volume

662.8K

Market Cap

$1.97B

P/E

Div Yield

Over the past 12 months, insider activity at Heartflow, Inc. Common Stock (HTFL) has been exclusively selling, with 0 insider purchases totaling $0.00 and 7 insider sales totaling $60.65M. The most recent insider transaction was by Farquhar John C.M. (director, officer: Chief Executive Officer), who sold $290.9K worth of shares on Mar 12, 2026. Heartflow, Inc. Common Stock operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $1.97B.

Buys (12M)

0

$0.00

Sells (12M)

7

$60.65M

Net Activity

Net Seller

$60.65M

Active Insiders

4

last 12 mo

HTFL Price Chart

HTFL Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 12, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell12,837$22.66$290.9K581,450
Mar 6, 2026Cullivan Julie AdirectorSell9,122$25.00$228.1K27,291
Feb 17, 2026Rogers Campbellofficer: Chief Medical OfficerSell65,153$24.49$1.60M76,034
Feb 12, 2026Rogers CampbellChief Medical OfficerSell65,153$24.49$1.60M0
Feb 10, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell22,562$27.46$619.6K591,656
Feb 6, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerSell2,000,000$28.05$56.10M10,448,200
Feb 6, 2026Cullivan Julie AdirectorSell8,000$27.32$218.6K36,413

HTFL Insider Buying Activity

The following table shows recent insider purchases of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.

No insider buying activity found for HTFL in the last 12 months.

HTFL Insider Selling Activity

The following table shows recent insider sales of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 12, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell12,837$22.66$290.9K581,450
Mar 6, 2026Cullivan Julie AdirectorSell9,122$25.00$228.1K27,291
Feb 17, 2026Rogers Campbellofficer: Chief Medical OfficerSell65,153$24.49$1.60M76,034
Feb 12, 2026Rogers CampbellChief Medical OfficerSell65,153$24.49$1.60M0
Feb 10, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell22,562$27.46$619.6K591,656
Feb 6, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerSell2,000,000$28.05$56.10M10,448,200
Feb 6, 2026Cullivan Julie AdirectorSell8,000$27.32$218.6K36,413

HTFL Insiders

Farquhar John C.M.

director, officer: Chief Executive Officer

Sold $910.4K
2 tradesLast: Mar 10, 2026
Cullivan Julie A

director

Sold $446.6K
2 tradesLast: Mar 5, 2026
Rogers Campbell

Chief Medical Officer

Sold $1.60M
1 tradesLast: Feb 12, 2026
Rogers Campbell

officer: Chief Medical Officer

Sold $1.60M
1 tradesLast: Feb 12, 2026
Bain Capital Life Sciences Investors, LLC

10 percent owner

Sold $56.10M
1 tradesLast: Feb 4, 2026